Astroglial reactivity is a key modulator of Alzheimer's disease pathological progression
Pelkmans W, Gispert JD.
Abstract
This scientific commentary refers to ‘Association of glial fibrillary acid protein, Alzheimer's disease pathology and cognitive decline’ by Peretti et al. (https://doi.org/10.1093/brain/awae211).
Reference
Pelkmans W, Gispert JD. Astroglial reactivity is a key modulator of Alzheimer's disease pathological progression. Brain. 2024 Nov 8;147(12):3973–5. doi: 10.1093/brain/awae354. Epub ahead of print. PMID: 39514769; PMCID: PMC11629679.
